Transformation on track: Strong foundations for sustainable competitiveness
The past financial year was shaped by structural changes across the industry, varying regional investment dynamics and continued cost pressures. While market conditions in Europe remained challenging, investment activity in the United States gained renewed momentum. Asia overall proved resilient, with Southeast Asia and India in particular providing important growth stimulus as key markets of the future. Growth was driven primarily by technologically sophisticated applications. Accordingly, the technical injection moulding segment performed well, supported by orders from sectors including logistics and aerospace. The medical segment continued to operate at a high level, while packaging developed more cautiously. “The challenges persist in what remains a highly volatile global environment,” said Stefan Engleder, CEO of the ENGEL Group. “We remain firmly committed to strengthening our global footprint and our high-performance sales and service organisation, enabling us to support our customers worldwide and create tangible added value for their success. Against this backdrop, ENGEL is advancing its internal transformation programme as planned, with the clear objective of further securing its long-term competitiveness.
Dual-brand strategy addressing diversified customer needs
ENGEL’s international production plants—established over several decades—together with its Austrian sites, which are being strategically aligned as part of the transformation initiative, form a robust global manufacturing network designed to meet evolving customer requirements. At the Changzhou plant in China alone, more than 1,000 injection moulding machines were produced in the 2025/26 financial year, with approximately 700 additional machines manufactured across facilities in Shanghai and Korea.
